Drugs.com - New Drug Approvals

ANI Pharmaceuticals Announces FDA Approval for Expansion of Iluvien Label

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Iluvien (fluocinolone acetonide...

Mar 14, 2025 - 23:15
 0
ANI Pharmaceuticals Announces FDA Approval for Expansion of Iluvien Label
BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Iluvien (fluocinolone acetonide...
Read More

Tags:

Previous Article

FDA Advises Consumers Not to Inhale Nitrous Oxide Products

Next Article

China Passenger Car Association CEO Warns Elon Musk Is Burning Up Consumer Deman...

Related Posts

Indivior Announces FDA Approval of Label Changes for Sublocade (buprenorphine extended-release) Injection

Indivior Announces FDA Approval of Label Changes for Su...

Mar 3, 2025  0

FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra

FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar t...

Feb 9, 2025  0

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn...

Feb 9, 2025  0